Prescription Skin Treatments from UK-Registered Doctors

Acne vulgaris is a chronic inflammatory condition of the pilosebaceous unit, driven by four key pathogenic factors: excess sebum production, follicular hyperkeratinisation, colonisation by Cutibacterium acnes (formerly Propionibacterium acnes), and inflammation.

Understanding these mechanisms explains why effective treatment often requires a multi-targeted approach.

Sebum overproduction is primarily androgen-driven, which explains acne's peak during adolescence and its association with polycystic ovary syndrome in women.

Dihydrotestosterone (DHT) stimulates sebaceous gland activity, increasing sebum output and creating the oily environment that C. acnes thrives in.

Follicular hyperkeratinisation causes the keratinocytes lining the hair follicle to become cohesive and accumulate, forming a microcomedone — the precursor lesion of all acne.

Microcomedones develop into open comedones (blackheads), closed comedones (whiteheads), or inflammatory papules, pustules, nodules, and cysts.

Acne severity is graded using the Leeds Revised Acne Grading System or the Global Acne Grading System:

• Mild: Predominantly comedonal with few inflammatory lesions
• Moderate: Mixed comedonal and papulopustular, wider distribution
• Severe: Extensive papulopustular or nodulocystic disease with scarring risk

Rosacea is a distinct condition affecting the central face, characterised by flushing, persistent erythema, papules, pustules, and telangiectasia.

• Erythematotelangiectatic (flushing and redness)
• Papulopustular (resembles acne but without comedones)
• Phymatous (skin thickening, typically rhinophyma)
• Ocular (eye involvement, blepharitis)

Other common prescription-requiring skin conditions include eczema (atopic dermatitis), psoriasis, fungal infections, and hyperpigmentation disorders.

Each requires a targeted treatment approach based on accurate diagnosis.

Topical therapy forms the foundation of acne and rosacea management, with specific agents selected based on the predominant lesion type and severity.

Retinoids are the cornerstone of acne treatment. They normalise follicular keratinisation, prevent microcomedone formation, and have anti-inflammatory properties. **Adapalene 0.

1% gel** is the NICE-recommended first-line topical retinoid due to its established efficacy and superior tolerability compared with tretinoin.

Apply a pea-sized amount to the entire affected area (not individual spots) every evening.

Initial irritation, dryness, and a purging phase (worsening for 2-4 weeks) are normal and settle by week 6-8.

Tretinoin (0.025%, 0.05%, 0.1% cream or gel) is a more potent retinoid that accelerates cell turnover, reduces comedones by 40-70%, and improves skin texture.

Start at the lowest concentration and increase as tolerance develops. Mandatory sun protection (SPF 30+) is required as retinoids increase photosensitivity.

Benzoyl peroxide (2.5-10%) has bactericidal action against C. acnes without inducing antibiotic resistance, making it an essential component of combination therapy.

It is available over the counter but is most effective when prescribed alongside a retinoid. The 2.5% concentration is as bactericidal as 10% but causes significantly less irritation.

Topical antibiotics — clindamycin 1% and erythromycin 2% — should always be combined with benzoyl peroxide to prevent resistance. NICE recommends against topical antibiotic monotherapy.

Fixed-dose combinations (Duac gel: clindamycin/BPO; Epiduo: adapalene/BPO; Treclin: clindamycin/tretinoin) simplify application and improve adherence.

Azelaic acid 15-20% has anti-inflammatory, anti-comedonal, and anti-pigmentary properties.

It is suitable for use in pregnancy (unlike retinoids) and is particularly effective for post-inflammatory hyperpigmentation.

For rosacea, first-line topical treatments include:

• Ivermectin 1% cream (Soolantra): anti-parasitic and anti-inflammatory, applied once daily for 12-16 weeks
• Metronidazole 0.75% gel/cream: applied twice daily, effective for papulopustular rosacea
• Brimonidine 0.33% gel (Mirvaso): alpha-2 agonist causing vasoconstriction, reduces erythema within 30 minutes but effects are temporary
• Azelaic acid 15% gel: alternative for papulopustular rosacea

When topical therapy alone is insufficient — typically after 8-12 weeks of consistent use — systemic treatments are the next step. The choice depends on acne severity, sex, and patient preference.

Oral antibiotics are the first-line systemic treatment for moderate inflammatory acne. NICE and the British Association of Dermatologists (BAD) recommend:

• Lymecycline 408 mg once daily or doxycycline 100 mg once daily for a maximum of 3 months
• Always prescribed alongside a topical retinoid and/or benzoyl peroxide to enhance efficacy and reduce resistance
• Tetracyclines are contraindicated in pregnancy and children under 12
• Erythromycin 500 mg twice daily is an alternative for patients intolerant of tetracyclines, though resistance rates are higher

Combined oral contraceptives (COC) are effective for female patients with hormonal acne, particularly when acne is concentrated on the jawline and lower face, worsens premenstrually, or coexists with PCOS.

Co-cyprindiol (Dianette) contains cyproterone acetate, a potent anti-androgen. Improvement takes 3-6 months, reflecting the slow turnover of pilosebaceous units.

Isotretinoin (Roaccutane) is the most effective treatment for severe, scarring, or refractory acne.

It targets all four pathogenic factors: reduces sebum production by up to 90%, normalises keratinisation, reduces C. acnes colonisation, and has potent anti-inflammatory effects.

Isotretinoin prescribing details:

• Dose: 0.5-1.0 mg/kg daily for 16-24 weeks, aiming for a cumulative dose of 120-150 mg/kg
• 85% of patients achieve complete or near-complete remission after a single course
• Relapse rate: approximately 20%, mostly within the first 3 years
• Mandatory pregnancy prevention: isotretinoin is a category X teratogen. Female patients require two forms of contraception, monthly pregnancy tests, and must be registered with the pregnancy prevention programme
• Monitoring: baseline and monthly liver function tests (ALT, AST), fasting lipids (triglycerides, cholesterol), and full blood count

Common isotretinoin side effects:

• Dry lips and skin (nearly universal — use emollients liberally)
• Dry eyes and reduced contact lens tolerance
• Musculoskeletal pain (10-15%)
• Mood changes: the relationship between isotretinoin and depression remains debated; a 2019 systematic review found no conclusive causal link, but patients should report mood disturbance promptly

Isotretinoin is prescribed exclusively by dermatologists or clinicians with specialist experience. Dr. Presc can refer patients who may benefit from isotretinoin to appropriate specialist services.

Prescription treatments work best within a consistent, gentle skincare routine.

Overly aggressive cleansing, exfoliation, or layering multiple active ingredients causes barrier damage that worsens both acne and rosacea.

Cleansing: Use a gentle, non-foaming, pH-balanced cleanser (pH 4.5-5.5) twice daily. Avoid soap, scrubs, and cleansing brushes, which strip the skin barrier and trigger rebound sebum production.

Micellar water or a ceramide-based cleanser suits most skin types. For rosacea, lukewarm water only — hot water dilates capillaries and exacerbates flushing.

Moisturising: Even oily, acne-prone skin requires a lightweight, non-comedogenic moisturiser.

Retinoid therapy disrupts the skin barrier, and failure to moisturise increases irritation, flaking, and treatment discontinuation.

• Ceramides and cholesterol (repair barrier function)
• Hyaluronic acid (humectant that draws water into the epidermis)
• Niacinamide (anti-inflammatory, reduces sebum, strengthens barrier)

Sun protection is non-negotiable when using retinoids, antibiotics (doxycycline), or azelaic acid. Apply a broad-spectrum SPF 30-50 every morning as the last step of your skincare routine.

Mineral filters (zinc oxide, titanium dioxide) are better tolerated by sensitive and rosacea-prone skin than chemical filters.

Treatment layering order (evening):

1. Cleanse

2. Wait until skin is fully dry (5-10 minutes for retinoids to reduce irritation)

3. Apply prescription treatment (retinoid, azelaic acid, or prescribed topical)

4. Moisturise over the top as a buffer if irritation is significant

Common mistakes to avoid:

• Using multiple actives simultaneously (retinoid + AHA + BHA + vitamin C = barrier destruction)
• Spot-treating with retinoids instead of applying to the whole affected area
• Stopping treatment after the purging phase, mistaking it for treatment failure
• Picking or extracting lesions, which drives bacteria deeper and increases scarring risk

Diet and lifestyle considerations: While diet does not cause acne, emerging evidence links high-glycaemic-index diets and frequent dairy consumption (particularly skimmed milk) with acne severity.

Stress management is clinically relevant, as cortisol increases sebum production and impairs wound healing.

Recognising when to intensify treatment prevents unnecessary scarring and prolonged distress. As a prescriber, I review response timelines carefully to ensure patients are on the optimal pathway.

Expected timelines for improvement:

• Topical retinoids: 8-12 weeks for visible improvement (initial purging is expected at weeks 2-4)
• Oral antibiotics: 6-8 weeks for significant reduction in inflammatory lesions
• Combined oral contraceptives: 3-6 months for hormonal acne
• Isotretinoin: initial flare possible in weeks 1-4, then progressive improvement over 16-24 weeks

Indications for treatment escalation:

• No improvement after 8-12 weeks of consistent topical therapy
• Moderate-to-severe inflammatory acne with scarring potential
• Acne causing significant psychological distress (depression, social withdrawal, body dysmorphia)
• Relapse within 3 months of completing oral antibiotics despite maintenance topical therapy
• Hormonal pattern acne in women not responding to first-line measures

Referral to dermatology is warranted when:

• Severe nodulocystic acne is present at initial presentation (fast-track for isotretinoin assessment)
• Two courses of oral antibiotics have failed
• Acne fulminans (acute onset with fever, arthralgia, and ulcerating lesions) — urgent referral
• Suspected underlying hormonal disorder (virilisation, Cushing's features)
• Significant scarring requiring discussion of procedural options (chemical peels, microneedling, laser resurfacing)

For rosacea, escalation from topical to systemic therapy (doxycycline 40 mg modified-release daily for 8-16 weeks) is indicated when papulopustular lesions persist despite 12 weeks of topical ivermectin or metronidazole.

Ocular rosacea requires co-management with ophthalmology.

Scarring is the most important outcome to prevent. Early, aggressive treatment of inflammatory acne reduces lifelong scarring. Post-inflammatory erythema (red marks) fades over 3-12 months.

Post-inflammatory hyperpigmentation responds to azelaic acid, retinoids, and sun protection.

Atrophic (ice-pick, boxcar, rolling) scars may require dermatological procedures once active acne is controlled.

Dr. Presc prescribers can escalate topical regimens, initiate oral antibiotics, and arrange specialist referrals where clinically indicated.